Non-alcoholic Steatohepatitis Clinical Trials

197 clinical trials for Non-alcoholic Steatohepatitis across international registries, including 18 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES) — RECRUITING · PHASE2
• Longitudinal Observational Study Of Chinese With NAFLD/NASH — RECRUITING
• Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial — RECRUITING · NA
• Identification of Liver Fibrosis Biomarkers — RECRUITING
• A Safety, Tolerability, Pharmacokinetics/Pharmacodynamics Study of HEC169584 Capsules in Healthy Subjects — RECRUITING · PHASE1
• CHronic Hepatopathies Associated With ALcohol Consumption aNd metAbolic Syndrome — RECRUITING
• Endoscopic Ultrasound Shear Wave Elastography in Patients With Non-alcoholic Fatty Liver Disease — RECRUITING
• "Constitution of a Biological Collection to Establish Preclinical Translational Models for the Study of Tumors and Chronic Liver Diseases". — RECRUITING
• Integrated Diagnostics for Early Diagnosis of Liver Disease — RECRUITING
• The Olmsted NAFLD Epidemiology Study (TONES) — RECRUITING · NA
• Blood Collection Biorepository for Liver Disease Research — RECRUITING
• InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer — RECRUITING
• Prognostic Significance of Fatty Liver Disease in Bariatric Patients — RECRUITING · NA
• Soluble Fibre Supplementation in NAFLD — RECRUITING · PHASE2
• Synbiotics and Fecal Microbiota Transplantation to Treat Non-Alcoholic Steatohepatitis — RECRUITING · PHASE2
• Efficacy and Safety of Recombinant Human FGF21-Fc Fusion Protein for Injection (TQA2225/AP025) in Adult Subjects With Non-alcoholic Steatohepatitis (NASH) — RECRUITING · PHASE2
• Reducing Non-Alcoholic Steatohepatitis — RECRUITING · NA
• European Paediatric Non-Alcoholic Fatty Liver Disease Registry (EU-PNAFLD) — RECRUITING
• A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2 STUDY TO EVALUATE EFFICACY AND SAFETY OF CP-945,598 IN SUBJECTS WITH NON-ALCOHOLIC STEATOHEPATITIS — TERMINATED · PHASE2
• Lifestyle induced weight loss and Liraglutide in the treatment of NASH — TERMINATED · PHASE2
• Effects of Exenatide (Byetta®) on biochemical and histological parameters of liver function in patients with Nonalcoholic Steatohepatitis (NASH) – a randomized, placebo-controlled, parallel-group trial — ACTIVE_NOT_RECRUITING · PHASE4
• The effect of semaglutide in subjects with non-cirrhotic non-alcoholic steatohepatitis — TERMINATED · PHASE3
• Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH) — ACTIVE_NOT_RECRUITING · PHASE3
• Hyperpolarized Pyruvate (13C) Magnetic Resonance Imaging In Patients With Fatty Liver Disease — COMPLETED
• Phase 2a Study to Evaluate Safety and Explore Efficacy of J2H-1702 for NASH — COMPLETED · PHASE2
• The Sonic Incytes Liver Incytes System, Evaluation of Liver Fibrosis and Steatosis Versus MRE and MRI PDFF — COMPLETED · NA
• Assessment of Fatty Liver With Thermo-acoustic Device — WITHDRAWN
• Combined Active Treatment in Type 2 Diabetes With NASH — COMPLETED · PHASE4
• A Phase 3, Multinational, Double-Blind, Randomized, Placebo-Controlled Study of MGL-3196 (resmetirom) in Patients With Non-Alcoholic Steatohepatitis (NASH) and Fibrosis to Resolve NASH and Reduce Progression to Cirrhosis and/or Hepatic Decompensation — TERMINATED · PHASE3
• To Evaluate the Efficacy and Safety of HSK31679 in Chinese Patients With Non-Alcoholic Steatohepatitis (NASH) . — COMPLETED · PHASE2
• A randomised, double-blind, placebo-controlled, multicentre, Phase 3 study evaluating efficacy and safety of lanifibranor followed by an active treatment extension in adult patient with non-cirrhotic non-alcoholic steatohepatitis (NASH) and fibrosis 2 (F2)/fibrosis 3 (F3) stage of liver fibrosis — TERMINATED · PHASE3
• IMPACT TRIAL: Efficacy and Safety of Pemvidutide in Subjects With Nonalcoholic Steatohepatitis (NASH) — COMPLETED · PHASE2
• The Referral to Hepatology Can be Improved Through an Electronic Medical Record (EMR)-Based Best Practice Alert (BPA) for an Appropriate Referral — COMPLETED · NA
• A Study to Test Whether Survodutide Helps People Living With Obesity or Overweight and With a Confirmed or Presumed Liver Disease Called Non-alcoholic Steatohepatitis (NASH) to Reduce Liver Fat and to Lose Weight (SYNCHRONIZE-MASLD) — COMPLETED · PHASE3
• Study of Oral Idebenone to Treat Non-Alcoholic Steatohepatitis — COMPLETED · PHASE1
• Effect of Patient Demographics, Comorbidities, and Medications on Severity of NASH Fibrosis — COMPLETED
• Simultaneous Quantification of Liver Fat Content, Fatty Acid Composition, and Fibrosis Using Spin-lock MRI for Steatohepatitis Assessment — ACTIVE_NOT_RECRUITING
• Safety, Tolerability, and Pharmacokinetics of ACT500 in Healthy Adult Participants — COMPLETED · PHASE1
• A Randomised, Open-Label, Single-Centre, Study to Evaluate the Bioequivalence of Lanifibranor — OTHER · PHASE1
• Pediatric Liver Fat Quantification (LFQ) Phase 2 Pilot Study — COMPLETED · NA
• Ultrasound-Based Liver Fat Quantification (LFQ) Pilot Study — COMPLETED · NA
• Phase 2 Study of MGL-3196 in Patients With Non-Alcoholic Steatohepatitis (NASH) — COMPLETED · PHASE2
• Efficacy and Tolerability of a Specialized Food Products for Dietary Therapeutic and Preventive Nutrition Based on Ice Cream (Ice Cream With Brazzein, Maltitol and Oligofructose; Ice Cream With Brazzein, Erythritol, Maltitol and Inulin) Compared to Standard (Sundae) Ice Cream — ACTIVE_NOT_RECRUITING · NA
• Exploratory Study to Assess the Short Term Effect on Liver Enzymes and the Safety of TRO19622 in Patients With Non-Alcoholic Steatohepatitis (NASH) — COMPLETED · PHASE2
• Investigate Safety, Tolerability, PK/PD of J2H-1702 in Healthy Females — COMPLETED · PHASE1
• Investigate Safety, Tolerability, PK/PK of J2H 1702 in Healthy Males — COMPLETED · PHASE1
• Non-alcoholic Fatty Liver Disease Parametric PET (FLiPP) Study — ACTIVE_NOT_RECRUITING
• A Physiologic Analysis of Endoscopic Sleeve Gastroplasty (ESG) — ACTIVE_NOT_RECRUITING · NA
• Repeatability and Reproducibility of Multiparametric MRI — COMPLETED
• Research Study on Whether a Combination of 2 Medicines (NNC0194 0499 and Semaglutide) Works in People With Non-alcoholic Steatohepatitis (NASH) — COMPLETED · PHASE2

Refine this search